CPS-11（Cat No.:I025173）is a novel bioactive peptide designed for research in cancer and metabolic disease therapies. It selectively inhibits key proteins involved in cell signaling pathways related to tumor growth and metabolic regulation. CPS-11 shows potential in reducing cancer cell proliferation and promoting apoptosis in targeted tumor types. Additionally, its role in regulating metabolic processes makes it a promising candidate for addressing metabolic disorders such as obesity and diabetes. Researchers are currently investigating CPS-11’s effectiveness in preclinical models to understand its therapeutic potential and safety profile.